Progress in research on methods for determination of active antigen content of rabies vaccine

Chinese Journal of Biologicals

Volumn 23, Issue 4, 2010, Pages 437-440

  Liu, Jin Hua ^a   Dong, Guan Mu ^a  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

Antigen; Determination method; Rabies vaccine

Indexed keywords

RABIES VACCINE; VIRUS ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CHROMATOGRAPHY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GOLD IMMUNOCHROMATOGRAPHIC ASSAY; IMMUNODIFFUSION;

EID: 77954479776     PISSN: 10045503     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. World Health Organization. WHO Expert Consultation on Rabies. 2004. First Report. WHO TRS, 931.
2. WHO Expert Committee on Biological Standardization. Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs. Geneva: WHO, 2005.
3. Meslin FX, Kaplan MM, Koprowski H, et al. Labortoary techniques in rabies. 4th ed. Geneva: WHO, 1996.
4. Ferguson M, Schild GC. A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies. J Gen Virol, 1982,59(Pt1):197-201. (Pubitemid 12155897)
5. Vogel I, Kundi M, Gerstl F. A modification of the single radial immunodiffusion potency test (SRD) for rabies vaccines. J Biol Stand, 1989,17(1):75-83.
6. Morag F, Alan H. Report of the WHO collaborative study to calibrate a candidate replacement for the Fifth International Standard for rabies vaccine. Expert Committee on Biological Standardization. Geneva: WHO, 2008.
7. Thraenhart O, Ramakishnan K. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera. J Biol Stand, 1989,17(4):291-309. (Pubitemid 20052106)
8. Fournier-Caruanal J, Poirier B, Haond G, et al. Inactivated rabies vaccine control and release: use of an ELISA method. Biologicals, 2003,31(1):9-16.
9. Nagarajan T, Reddy GS, Mohana Subramanian B, et al. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture. Biologicals, 2006,34(1):21-27.
10. Rooijakkers EJM, Uittenbogaard JP, Groen J, et al. Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing. J Virol Meth, 1996,58(1-2):111-119.
11. Jallet C, Jacob Y, Bahloul C, et al. Chimeric lyssavirus glycoproteins with increased immunological potential. J Virol, 1999,73(1):225-233. (Pubitemid 28565364)
12. Discussion on WHO requirements for rabies vaccine for human use. Geneva: WHO, 2004.
13. Katayama S, Yamanaka M, Ota S, et al. A new quantitative method for rabies virus by detection of nucleoprotein in virion using ELISA. J Vet Med Sci, 1999,61(4):411-416. (Pubitemid 129620061)